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Abstract: Background and objectives: Several anthropometric and body composition parameters
have been linked to arterial stiffness (AS) as a biomarker of cardiovascular disease. However,
little is known about which of these closely related factors is more strongly associated with AS.
The aim of the present study was to analyze the relationship of different anthropometric and body
composition parameters with AS in middle-aged adults. Materials and Methods: This cross-sectional
study included 186 middle-aged participants (85 women, 101 men; age = 42.8 ± 12.6 years) evaluated
as part of the Healthy UAL study, a population study conducted at the University of Almería
with the main purpose of analyzing the etiology and risk factors associated with cardio-metabolic
diseases. Anthropometric measures included neck, waist, and hip circumferences, as well as the
waist-to-height ratio (WHtr). Bioimpedance-derived parameters included fat-free mass index (FFMI),
fat mass index (FMI), and percent of body fat (%BF). AS was measured by pulse wave velocity
(PWV). The relationships of interest were examined through stepwise regression analyses in which
age and sex were also introduced as potential confounders. Results: Neck circumference (in the
anthropometric model; R2: 0.889; β: age = 0.855, neck = 0.204) and FFMI (in the bio-impedance
model; R2: 0.891; β: age = 0.906, FFMI = 0.199) emerged as significant cross-sectional predictors
of AS. When all parameters were included together (both anthropometry and bio-impedance),
both neck circumference and FFMI appeared again as being significantly associated with AS (R2: 0.894;
β: age = 0.882, FFMI = 0.126, neck = 0.093). Conclusion: It was concluded that FFMI and neck
circumference are correlated with AS regardless of potential confounders and other anthropometric
and bioimpedance-derived parameters in middle-aged adults.
Keywords: arterial stiffness; body composition; obesity; cardiovascular disease; adults
1. Introduction
Cardiovascular diseases (CVDs) are one of the main groups of non-communicable diseases [1],
as well as the leading cause of morbidity and mortality worldwide [2,3]. Currently, the economic
burden of CVD in Europe is estimated at 196,000 million euros per year, approximately 54% of the total
health expenditure [4]. Consequently, identification of the main risk factors for CVD has become a
matter of great clinical and public health interest.
Arterial stiffness (AS) is a marker of subclinical atherosclerosis [5] characterized by a reduced
elasticity in the arterial wall. AS is closely related to the development of endothelial dysfunction [6]
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and has been shown to predict not only cardiovascular disease but also all-cause deaths [7]. AS can
be measured by different non-invasive methods, although the most common is analysis of the pulse
wave velocity (PWV). Among the different techniques proposed for the assessment of PWV, one of
the most commonly used is that in which, once the pulse wave is captured at the brachial artery
level, a step algorithm is applied to derive the aortic pressure wave [8]. In fact, aortic PWV has been
identified as a strong predictor of future CV events and all-cause mortality, especially in subjects with
higher baseline cardiovascular risks than the general population [9]. Therefore, the identification of
potential modifiable factors associated with increased AS may ultimately lead to the implementation
of strategies for the prevention of CVD and all-cause mortality even in apparently healthy individuals.
Aging reduces arterial elasticity and has been identified as the main precursor of arterial stiffness
in different populations [10]. Among other potential factors, body composition (i.e., a health-related
component of physical fitness [11]) may be associated with AS even in healthy people. For instance,
simple anthropometric indices, such as waist circumference [12], waist-to-height ratio (WHtr) [13],
body mass index (BMI) [14], and hip circumference [15], have all been shown to be directly associated
with AS. Recently, other authors have shown an independent association between neck circumference
and AS above and beyond other measures of adiposity [16]. Some authors have also explored the
relationship between AS and body composition measures by considering complex indexes generated
from bioimpedance in healthy adults, such as the body fat percentage (%BF) [17], or indexes in which
the individual’s height is included, such as fat mass index (FMI) or fat-free mass index (FFMI) [18].
The above-mentioned studies assessed the association of AS with obesity in isolation using either
simple (anthropometric measures) or complex (derived from bioimpedance) measures. However,
a comprehensive characterization of the relationship between obesity-related parameters (including
both simple and complex measures) and AS in apparently healthy individuals is currently lacking.
Most importantly, it is still unclear whether simple anthropometric measures are just as good or better
predictors of AS than complex measures of adiposity. Gaining insight into this issue is relevant from
a clinical standpoint, because simple measures (such as neck or waist circumference) can easily be
incorporated into clinical practice. Consequently, the aim of the present study was to examine the
multivariate relationships between different anthropometric or body composition parameters and AS
in a sample of middle-aged adults.
2. Materials and Methods
2.1. Study Design
Healthy UAL (University of Almería) is a cross-sectional, observational, and descriptive population
study designed and carried-out at the University of Almería (UAL), Spain, with the overall aim of
investigating the etiology and risk factors of non-communicable diseases, especially cardio-metabolic
diseases. In total, 186 middle-aged adults were evaluated between February 2018 and January 2019. All
assessments were performed by two evaluators with two years of experience in exercise physiology and
physical activity epidemiology. Each participant’s health evaluation lasted approximately 30 minutes
and was carried out early in the morning (from 08:30 for the first appointment to 10:30 for the last
one), in our sport science laboratory (a temperature-controlled room, 22–24 ◦C). This study is reported
in accordance with the STROBE guidelines (Strengthening the Reporting of Observational Studies in
Epidemiology) [19].
2.2. Participants and Procedures
Participants were invited to participate through social networks (mainly Facebook, Twitter,
and WhatsApp), local newspapers, and UAL’s press office (which actually includes UAL’s website,
mailing list, and radio station). All participants’ appointments were individually scheduled by e-mail
in order to accommodate the participants’ timetable preferences.
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Inclusion criteria were: Being over 18 years of age, possessing adequate reading capacity to
understand and complete the questionnaires, as well as enough functional capacity to perform different
submaximal physical fitness tests. The inclusion of pregnant women was not contemplated due to
the peculiarities of this physiological state. Participants were requested not to eat/drink or to take a
shower 2 h before the evaluation. Likewise, they were requested not to exercise or drink coffee for 24 h
before the examination. All women’s evaluations were performed when they were not menstruating.
This study was approved by the Bioethics Committee of the University of Almería (UAL) (Ref:
UALBIO2018/016), and all participants were required to read and sign an informed consent form.
Figure 1 shows the selection process used for the participants. Out of a total of 209 participants
who contacted us, 18 did not attend their evaluation appointment, 1 did not meet the inclusion criteria
(due to pregnancy), and 4 were excluded due to incomplete data (2 for body composition and 2 for
PWV data). A total of 186 adults, 85 women and 101 men (men age = 42.8, SD = 12), met the inclusion
criteria, agreed to participated, and had valid data on all needed parameters.
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2.3. Socio-Demographic Data
Participants filled out a questionnaire comprising a variety of socio-demographic questions taken
from the Spanish version of the European Health Interview Survey (EHIS) and the European Health
Survey in Spain 2014, conducted by the National Institute of Statistics (INE) with the collaboration of
the Spanish Ministry of Health, Social Services, and Equality (MSSSI). Participants were asked to report
their birthdate, sex, place of birth, nationality, postal code, civil status, education level, and occupational
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status. Participants were also asked if they had ever been diagnosed with different diseases, such as
arrhythmias, infarction, angina pectoris, stroke, diabetes, cancer, thrombosis, embolism, pulmonary
bronchitis, or hypertension. This survey was sent to participants via email 2 to 3 days before the
evaluation to be filled out at home.
2.4. Body Composition Assessment
Height was measured with a portable system (SECA 213, Hamburgo, Germany), and with the
patient shoeless in a standing position. Electric bioimpedance (Inbody 120; Biospace Co., Seoul,
Korea) was used to measure fat mass (FM), fat-free mass (FFM), and percentage of body fat (%BF).
All participants were asked to urinate before the evaluation, and to fast for 2 h. The fat mass index (FMI)
was calculated as fat mass (kg)/height2 (m), while FFMI was calculated as fat free mass (kg)/height2
(m). The body mass index (BMI) was calculated as weight (kg) divided by height squared (m2).
WHtr was calculated as the waist circumference (cm) divided by height (cm), and was considered to
represent low cardio-metabolic risk when the value was below 0.5 [20]. Anthropometric measurements
(neck, waist, and hip circumferences) were made with a Rosscraft tape measure and according to the
recommendations of the International Society for Advancement of Kinanthropometry (ISAK) [21].
All measures were taken in a standing position while the patient had his/her arms crossed about the
thorax. Neck circumference was measured at the lower margin of the thyroid cartilage, with the head
erect. Waist circumference was measured at the minimum abdominal girth between the lower costal
margin and the iliac crest. Hip circumference was measured at the level of the maximal protrusion of
the gluteal muscles. Each circumference was measured twice non-consecutively and the mean of both
measurements was used for the analysis. If the measurements differed by more than 0.5 cm, a third
measurement was taken, and the two most similar readings were used in the analyses.
2.5. Pulse Wave Velocity (PWV) Evaluation
PWV was estimated via oscillometry using an ambulatory blood pressure monitoring and pulse
analysis system Mobil-O-Graph®(IEM GmbH, Stolberg, Germany). This device calculates PWV
as a marker of aortic stiffness, estimated from the waveform of the aortic pulse reconstructed by
mathematical models, taking into account impedance and age, as well as the Windkessel model of three
elements [22]. In accordance with the requirements of the British Hypertension Society standard, the
Mobil-O-graph is a valid instrument for clinical use [23] and Weiss et al [24] have shown no significant
differences between the central systolic pressure estimates from SphygmoCor and those obtained using
the Mobil-O-Graph. Furthermore, while repeated measurements were made, no significant differences
were found when comparing intra-rater reproducibility between both devices [24].
PWV was measured while the participants were resting silently in a sitting position for 5 minutes,
with the cuff placed on the upper arm around the brachial artery and with the palm facing up. The
reference value suggested when adjusting the age for healthy people is below 10 m/seg [25]. This
method has previously been shown to be a valid and reliable technique for measuring PWV and central
blood pressure in different populations [10] and is recommended for clinical use [26]. In Healthy UAL,
PWV was obtained from a single measurement, as previously investigated, bringing the use of central
blood pressure one step closer to routine clinical practice [24].
2.6. Statistical Analysis
All variables were graphically inspected for normality using histograms. Data are expressed as
mean and SD. The effect size of the differences between men and women was estimated as weighted
standardized mean differences [27] and 95% confidence intervals. The bivariate associations between
variables were examined using Pearson’s correlation coefficients. Three stepwise linear regression
models were used to examine which body composition variables were independently associated with
PWV. In model 1, age, sex, and anthropometric parameters (BMI, neck, waist, and hip circumferences,
WHtr) were introduced as potential independent variables. In model 2, age, sex, and bio-impedance
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parameters (FFMI, FMI, and %BF) were introduced as potential independent variables. In model 3, age,
sex, and all previously mentioned anthropometric and bio-impedance parameters were introduced as
potential independent variables. Statistical analyses were performed using the SPSS V.24.0 statistical
software package (IBM SPSS Statistics, Chicago, IL, USA), and statistical significance was determined
at the 5% level.
3. Results
Table 1 shows the means, standard deviations, and effect size of differences across sex for the
study variables. In general, men were heavier, taller, and presented more fat-free mass and less fat
mass compared to women. Men also had higher PWV values than women. Most frequent diseases
self-reported by participants were dyslipidemia (n = 51, 27.4%), hypertension (n = 22, 11,8%), anxiety
(n = 20, 10.8%), osteoarthritis (n = 16, 8.6%), depression (n = 12, 6.5%), myocardial infarction (n = 10,
5.4%), chronic bronchitis-emphysema-COPD (n = 9, 4.8%), cancer (n = 8, 4.3%), osteoporosis (n = 6,
3.2%), diabetes (n = 5, 2,7%), heart arrhythmia (n = 3, 1.6%), sleep apnea (n = 3, 1.6%), stroke (n = 1,
0.05%), pulmonary embolism (n = 1, 0.05%), deep vein thrombosis (n = 1, 0.05%), angina pectoris (n = 0,
0%), and heart failure (n = 0, 0%). We have no specific information on when the disease was diagnosed.
Nearly 80% of participants reported having a university degree (data not shown).
Table 1. Descriptive characteristics of the study sample.
All (n = 186) Women (n = 85) Men (n = 101)
Effect size of
differences gHedges
(95% CI)
Age (year) 42.2 ± 13.0 41.4 ± 13.5 42.8 ± 12.6 0.16 (−0.18; −0.39)
Weight (kg) 74.4 ± 14.2 65.4 ± 10.5 82.0 ± 12.4 1.43 (1.10; 1.75)
Neck circumference (cm) 36.9 ± 4.2 33.6 ± 2.8 39.6 ± 3.0 2.07 (1.71–2.42)
Waist circumference (cm) 86.2 ± 12.66 79.4 ± 10.7 91.9 ± 11.3 1.13 (0.82; 1.44)
Hip circumference (cm) 103.5 ± 7.5 102.4 ± 7.6 104.5 ± 7.2 0.27 (−0.01; −0.56)
WHtr (cm) 0.50 ± 0.07 0.48 ± 0.07 0.52 ± 0.07 0.55 (0.25; −0.84)
BMI (kg/m2) 25.5 ± 4.0 24.4 ± 4.2 26.3 ± 3.6 0.49 (0.19; 0.78)
FMI (kg/m2) 6.97 ± 3.13 7.92 ± 3.33 6.17 ± 2.72 −0.58 (−0.87; −0.28)
FFMI (kg/m2) 18.5 ± 2.5 16.4 ± 1.7 20.2 ± 1.6 2.25 (1.89; 2.62)
%BF (%) 26.8 ± 8.9 31.5 ± 8.2 22.8 ± 7.4 −1.12 (−1.43; −0.81)
PWV (m/s) 6.40 ± 1.30 6.12 ± 1.29 6.64 ± 1.25 0.41 (0.12; −0.70)
Data shown as mean ± SD, except for gHedges (95% CI). WHtr, waist-to-height ratio; BMI, body mass index; FFMI,
fat-free mass index; FMI, fat mass index; %BF, percentage of body fat; PWV, pulse wave velocity.
Bivariate associations are shown in Table 2. Pearson’s correlation coefficients showed significant
associations between PWV and all study variables, ranging from weak (hip, r = 0.260) to strong (age,
r = 0.923). The results of the correlational analysis segmented by gender (not shown) were very similar
and did not suggest a different pattern of relationships for men and women.
Table 2. Bivariate correlations (r) between the study variables.
PWV Age Weight Neck Waist Hip WHtr BMI PBF FFMI FMI
PWV -
Age 0.923 *** -
Weight 0.316 *** 0.161 *** -
Neck 0.487 *** 0.332 *** 0.850 *** -
Waist 0.548 *** 0.433 *** 0.866 *** 0.822 ** -
Hip 0.260 *** 0.146 * 0.796 *** 0.578 *** 0.737 *** -
WHtr 0.605 *** 0.522 *** 0.688 *** 0.752 *** 0.936 *** 0.692 *** -
BMI 0.439 *** 0.326 *** 0.811 *** 0.713 *** 0.851 *** 0.810 *** 0.876 *** -
%BF 0.303 *** 0.354 *** 0.141 0.046 * 0.343 *** 0.526 *** 0.570 *** 0.567 *** -
FFMI 0.274 *** 0.083 0.822 *** 0.811 *** 0.693 *** 0.479 *** 0.510 *** 0.551 *** −0.246*** -
FMI 0.359 *** 0.335 *** 0.404 *** 0.294 *** 0.559 *** 0.687 *** 0.734 *** 0.807 *** 0.916 *** −0.009 -
PWV (pulse wave velocity); WHtr (waist-to-height ratio); BMI (body mass index); %BF (percentage of body fat);
FFMI (fat-free mass index); FMI (fat mass index). * p < 0.05; ** p < 0.01; *** p < 0.001.
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The results of regression analyses (Table 3) showed that age was the variable explaining the major
proportion of variance for PWV, which was the case for all three tested models. Apart from age, the
variables entered into the models for stepwise regression analysis were neck circumference (in model
1), FFMI (in model 2), and both FFMI and neck circumference (in model 3). The explained variance
ranged from 0.889 (model 1) to 0.0894 (model 3). A post-hoc power analysis conducted using G*Power
3.9.1.4 [28] showed that, considering both a significance level of 0.05 and a statistical power (1–β) of
0.80, the sample size employed (n = 186) would have been sufficient to allow the entry of an additional
independent variable explaining a significant increase in R2 of at least 0.006.
Table 3. Stepwise regression analysis predicting arterial stiffness (Pulse wave velocity, PWV) from age
and body composition parameters.
F R2 B (β) SE B t p
Model 1
(Anthropometry) 731.307 0.889 <0.001
Age 0.085 (0.855) 0.003 32.736 <0.001
Neck circumference 0.063 (0.204) 0.008 7.802 <0.001
Model 2
(Bioimpedance) 749.885 0.891 <0.001
Age 0.090 (0.906) 0.002 37.056 <0.001
FFMI 0.103 (0.199) 0.013 8.147 <0.001
Model 3
(Anthropometry +
Bio-impedance)
509.557 0.894 <0.001
Age 0.088 (0.882) 0.003 32.393 <0.001
FFMI 0.065 (0.126) 0.023 2.870 0.005
Neck circumference 0.029 (0.093) 0.014 2.009 0.046
Model 1 included age, sex, body mass index (BMI), neck circumference, waist circumference, hip circumference, and
waist-to-height ratio (WHtr). Model 2 included age, sex, fat-free mass index (FFMI), fast mass index (FMI), and %
body fat (%BF). Model 3 included age, sex, BMI, neck, waist, hip, WHtr, FFMI, FMI, and %BF. β = standardized
regression coefficient.
4. Discussion
The aim of the present study was to examine the multivariate relationships between different
anthropometric or body composition parameters and AS in middle-aged adults. The main findings
indicate that both neck circumference (among anthropometric parameters) and FFMI (from
bio-impedance analysis) were associated with AS in middle-aged individuals.
Similar results to ours have been obtained in obese people when comparing BMI, waist, hip,
and neck measurements, showing a positive association between neck circumference and AS [16].
Likewise, in another study of obese populations, neck circumference was also the most powerful marker
of visceral adiposity, with a higher prediction capacity for the cardio-metabolic profile compared
to BMI, waist, and hip measurements [29]. In our analysis, we also included WHtr, which was
similar to a previous study of HIV-infected and non-infected people in which neck measurements
showed positive associations with different cardio-metabolic parameters, such as insulin levels or
lipid profiles, compared to waist, hip, and WHtr measurements [30]. BMI has been researched for
years as an independent predictor of CVD risk [31], but in our study, we found that it is no better at
predicting PWV than neck measurements. This is in general agreement with the other studies already
mentioned, in which neck measurements were better than BMI [16,29] in predicting cardio-metabolic
risk. Furthermore, in Framingham’s prospective study, it was observed that neck measurements were
a better predictor of type 2 diabetes than waist measurements or BMI [32]. In a study using both
healthy, obese, and diabetic people, WHtr and waist circumference were found to be better predictors
of PWV compared to BMI and %BF [12]. Nevertheless, in this study, neck measurements were not
taken into consideration. Previously, in other studies in which neck circumference was not measured,
the importance of waist measurement to predict PWV in comparison to BMI was confirmed [33]. It
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was observed that when the waist and neck circumferences are compared in relation to CVD risk
prediction, neck circumference (as a proxy of upper-body fat) was a better indicator of metabolic risk
than waist in a sample of 2029 elderly Chinese [34]. In addition, it was also stated that men with a
neck circumference <38 cm (<35 cm in the case of women) did not require additional evaluation [34].
Several authors conclude that neck circumference is easier to measure than that of the waist due to the
different protocols available during evaluations (i.e., where to take the measurement, with or without
clothes, state of respiration, etc.) that can affect the final measurement result [29,34]. These issues can
also be applied to other measurements, such as hip circumference, BMI, or WHtr, but are not present in
the case of measuring neck circumference [34]. Inter- and intra-rater reliability have been shown to
be good (ICC = 0.75–0.95) or excellent (ICC = 0.95–0.99), although most of the studies are focused on
children and adolescents [35].
The possible mechanisms that explain the association between necks´ adipose tissue and risk
factors, such as AS, have not yet been precisely identified. It has been suggested that upper-body
fat is responsible for a higher release of systemic fatty acids and a higher inflammatory state,
particularly in obese people [36]. An increase in circulating levels of free fatty acids can result in
oxidative stress and vascular injury [34]. Upper-body adipose tissue is more lipolytically active
than lower-body adipose tissue under basal conditions in both men and women [37]. Peripheral
adipose tissue has higher lipoprotein lipase activity and low fatty acid turnover and shows an
increased secretion of anti-inflammatory adipokines, whereas central fat shows a higher secretion of
pro-inflammatory markers [38]. As previously mentioned, neck circumference has been associated with
insulin resistance [16], and insulin resistance could increase AS through enhanced sympathetic activity
leading to vasoconstriction and through a rise in tubular sodium reabsorption [39]. Hyperinsulinemia,
strictly related to abdominal obesity, reduces the vasodilatory capacity of insulin, thereby reducing the
production of nitric oxide by endothelial cells [40].
According to the results produced in our second predictive model (the one using bio-impedance
parameters), FFMI and age seem to be the best predictors of PWV. While no other studies have been
found using the same tools as our investigation to measure body composition, a lot of research has
been carried out on cardiovascular risk markers other than AS. It should also be noted that fat-free
mass represents the weights of muscle, bone, and internal organs [41] and we found several examples
of different research approaches relating to our analysis, but where FFMI was evaluated, like lean
body mass, with measurements taken by means of bioimpedance, skinfolds, or a Dual-energy X-ray
absorptiometry (DXA) scanner. In general, our data are in line with the results from a study of
adolescents, in which lean mass (derived from skinfold and bioimpedance measurements) was one
of the variables most strongly associated with cardiovascular risk parameters, such as systolic blood
pressure, maximal oxygen uptake (VO2max), or triglycerides [42]. Another study that produced similar
results to ours compared body composition with blood pressure, showing a positive relationship
between lean body mass (measured by skinfolds) and blood pressure in both women and men and
from youth through to adulthood [43]. Likewise, another study of children in this population indicated
that lean mass (measured using DXA) is an important predictor of blood pressure [44]. While our
sample comprised adults only, different authors have found that in a sample of middle-aged people, a
positive relationship exists between central AS and lean body mass when controlling for %BF [45].
This association has not only been investigated regarding cardiovascular risks but also in regards
to mortality. A recent study has indicated that a high FFMI is associated with a higher risk of
cardiovascular mortality (just as much as an excess of body fat) [46].
The physiological mechanisms that could explain the relationship between fat-free mass and
cardiovascular risks are complex. They may be related to the fact that a higher lean mass leads
to a higher circulating blood volume, thus increasing the left ventricular stroke volume, and as a
consequence, cardiac output [42]. Other authors have suggested that these changes place an extra
burden on the heart, resulting in ventricular (both left and right) alterations that ultimately lead to
ventricular hypertrophy and enlargement, similar to the changes that occur in obesity [46]. Lean mass
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is a tissue with a much higher metabolic demand than body fat [47]. However, this subject requires
further investigation as other studies have reported evidence to the contrary. Other results that differ
from ours can therefore be found, although it should be noted that the tools and variables used in
these studies are not the same as those that we used. Different authors have claimed that low muscle
mass (measured as low creatinine excretion) predicts the development of CVD and all-cause mortality
in the general population [48]. It has also been shown that sarcopenia is an independent risk factor
for CVD [49,50]. Many authors have tried to find a physiological mechanism to explain this, going
so far as suggesting that sarcopenia is perhaps accompanied by a simultaneous increase in fat mass.
This lipid infiltration could also sustain a macrophage mediated release of pro-inflammatory cytokines
and adipokines from adipocytes, inducing chronic inflammation [51]. In a recent systematic review
and meta-analysis derived from observational studies, it was found that low muscle tissue mass is
consistently associated with increased AS. As a result of an increase in AS, muscle tissue loss can be
produced by heavily calcified and stiff blood vessels that may restrict nutrient supply to the muscle
tissue causing atrophy [52].
Our study has several limitations that we must acknowledge. First, its cross-sectional nature
prevents us from drawing causal conclusions. Second, body composition variables were derived from
electrical bio-impedance, a method that, despite being feasible in large-scale epidemiological studies,
is not yet considered the “gold standard” for body composition assessment [53,54]. Furthermore,
we recognize that our study population may not be a particularly representative sample, since the
participants were invited to participate via social networks. Thus, they might be more interested in
health monitoring than the general population, which may affect the generalizability of our results.
Finally, we asked participants about the most frequent physician-diagnosed diseases in their lifetime,
but thyroid diseases were not among them, which can actually affect neck measurement. As the
main strength of the present study, it should be highlighted that an ample range of body composition
parameters were considered in a fairly sex-balanced sample.
5. Conclusions
In summary, the findings from the present study point to neck circumference and FFMI as two
potential cross-sectional predictors of AS in apparently healthy middle-aged adults. The similar
cross-sectional predictive capacity shown by these two parameters when considered individually,
along with the simplicity and feasibility of the neck circumference assessment technique, support
their use in clinical evaluations aimed at characterizing CVD risk in asymptomatic middle-aged men
and women. Further research is still needed, however, to clarify the long-term influence of different
anthropometric and body composition parameters on the development of AS.
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